Maryland · 2026 Regular Session · Bill
HB 1461: Health Insurance - Coverage for Specialty Drugs - Rheumatologic Conditions
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 1461 is a bill introduced in the Maryland House on February 13, 2026. According to its official title, it concerns: Health Insurance - Coverage for Specialty Drugs - Rheumatologic Conditions. Primary sponsor: Deni Taveras (Democratic), Mary Lehman (Democratic), Nicole Williams (Democratic). Most recent recorded action (March 13, 2026): Hearing 3/13 at 1:30 p.m.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Sponsors
Sponsors by party (alphabetical): Democratic 3
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Deni Taveras | Primary sponsor | Democratic | House | 47B |
| Mary Lehman | Primary sponsor | Democratic | House | 21 |
| Nicole Williams | Primary sponsor | Democratic | House | 22 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- Hearing 3/13 at 1:30 p.m.
- Hearing canceled
- Hearing 3/13 at 3:00 p.m.
- Hearing canceled
- Hearing 3/13 at 1:00 p.m.
- First Reading Health